Drug-assisted synthesis of copper nanoparticles and their induction of cuproptosis and necrosis for breast cancer therapy
Journal of Zhejiang University-SCIENCE B · 2025
DOI: 10.1631/jzus.b2400163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Zhejiang University-SCIENCE B, 2025. Verfasst von Yuewen Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Sciences…. Hauptthemen laut MEDLINE: Breast Neoplasms, Copper, Metal Nanoparticles. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: the National Natural Science Foundation of China, the Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Neurokinin-1 receptor (NK1R), a member of the G protein-coupled receptor (GPCR) family, contributes to multiple pathological processes, including pain, chronic inflammation, and cancer (Gutierrez et al., 2019; Robinson et al., 2023). Current reports and our previous work have proven that NK1R is highly expressed in many cancer cells, such as colorectal cancer and leukemia, and that targeted blocking of NK1R can effectively inhibit tumor cell proliferation (Li XQ et al., 2013; Li JY et al., 2016; Ge et al., 2019; Shi et al., 2021). In addition, GPCRs have been found not only in the plasma membrane but also in the membranes of endosomes and lysosomes with endocytosis (Irannejad et al., 2017; Yarwood et al., 2017), which is more pronounced in cancer cells with highly developed lysosomes (Ramírez-García et al., 2019). 铜离子在铜死亡中发挥着关键作用,过量的Cu(I)离子不仅可与脂酰化二氢脂酰胺S-乙酰转移酶(DLAT)结合,诱导其寡聚,还能降低铁-硫簇蛋白的稳定性,从而共同引发细胞铜死亡。在高氧化水平的肿瘤微环境中,单质铜纳米颗粒能够被氧化生成Cu(I)离子。因此,本研究以药物阿瑞匹坦作为稳定剂,辅助合成无载体的药物-铜纳米粒子。通过扫描电子显微镜(SEM)、透射电子显微镜(TEM)、X射线衍射谱(XRD)、X射线光电子能谱(XPS)和傅立叶变换红外光谱(FIIR)等表征手段,证实铜-阿瑞匹坦纳米颗粒的顺利制备。激光共聚焦显微镜成像显示,该纳米颗粒通过内吞作用进入细胞溶酶体。在溶酶体酸性环境中,铜-阿瑞匹坦纳米颗粒发生pH响应性降解,释放出药物。此外,通过阿瑞匹坦和铜死亡的双模作用,乳腺癌细胞增殖被显著抑制。综上,本研究提供了一种无载体药物-铜纳米颗粒的制备方法,为实现药物介导和铜死亡介导的协同肿瘤治疗提供了新策略。.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
- Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou 450046, China.
- Zhejiang Provincial Engineering Research Center of New Technologies and Applications for Targeted Therapy of Major Diseases, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China. c…
Förderung
- the National Natural Science Foundation of China
- the Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Wang, Y., Gao, J., Cheng, Y., Pan, H., Tang, H., & Liu, C. (2025). Drug-assisted synthesis of copper nanoparticles and their induction of cuproptosis and necrosis for breast cancer therapy. Journal of Zhejiang University-SCIENCE B. https://doi.org/10.1631/jzus.b2400163
Vancouver
Wang Y, Gao J, Cheng Y, Pan H, Tang H, Liu C. Drug-assisted synthesis of copper nanoparticles and their induction of cuproptosis and necrosis for breast cancer therapy. Journal of Zhejiang University-SCIENCE B. 2025. doi:10.1631/jzus.b2400163
BibTeX
@article{Wang2025,
author = {Wang, Yuewen and Gao, Jingjie and Cheng, Yuying and Pan, Hanling and Tang, Hanxiao and Liu, Chenguang},
title = {Drug-assisted synthesis of copper nanoparticles and their induction of cuproptosis and necrosis for breast cancer therapy},
journal = {Journal of Zhejiang University-SCIENCE B},
year = {2025},
doi = {10.1631/jzus.b2400163}
}
EUVIMED